Home >> Pharmaceuticals >> Food & Beverage >>

Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 31 | Code: MRS - 18307

Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Vanda Pharmaceuticals Inc. - Product Pipeline Review - 2015’, provides an overview of the Vanda Pharmaceuticals Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vanda Pharmaceuticals Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Vanda Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Vanda Pharmaceuticals Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Vanda Pharmaceuticals Inc.’s pipeline products

Reasons to buy

- Evaluate Vanda Pharmaceuticals Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Vanda Pharmaceuticals Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Vanda Pharmaceuticals Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Vanda Pharmaceuticals Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vanda Pharmaceuticals Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Vanda Pharmaceuticals Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Vanda Pharmaceuticals Inc. Snapshot 4
Vanda Pharmaceuticals Inc. Overview 4
Key Information 4
Key Facts 4
Vanda Pharmaceuticals Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Vanda Pharmaceuticals Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Vanda Pharmaceuticals Inc. - Pipeline Products Glance 9
Vanda Pharmaceuticals Inc. - Late Stage Pipeline Products 9
Pre-Registration Products/Combination Treatment Modalities 9
Filing rejected/Withdrawn Products/Combination Treatment Modalities 10
Vanda Pharmaceuticals Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Vanda Pharmaceuticals Inc. - Drug Profiles 12
tasimelteon 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
iloperidone 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
tradipitant 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Vanda Pharmaceuticals Inc. - Pipeline Analysis 18
Vanda Pharmaceuticals Inc. - Pipeline Products by Target 18
Vanda Pharmaceuticals Inc. - Pipeline Products by Route of Administration 19
Vanda Pharmaceuticals Inc. - Pipeline Products by Molecule Type 20
Vanda Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 21
Vanda Pharmaceuticals Inc. - Recent Pipeline Updates 22
Vanda Pharmaceuticals Inc. - Dormant Projects 27
Vanda Pharmaceuticals Inc. - Discontinued Pipeline Products 28
Discontinued Pipeline Product Profiles 28
iloperidone 28
tasimelteon 28
Vanda Pharmaceuticals Inc. - Locations And Subsidiaries 29
Head Office 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 30
Disclaimer 31

List of Tables
Vanda Pharmaceuticals Inc., Key Information 4
Vanda Pharmaceuticals Inc., Key Facts 4
Vanda Pharmaceuticals Inc. - Pipeline by Indication, 2015 6
Vanda Pharmaceuticals Inc. - Pipeline by Stage of Development, 2015 7
Vanda Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2015 8
Vanda Pharmaceuticals Inc. - Pre-Registration, 2015 9
Vanda Pharmaceuticals Inc. - Filing rejected/Withdrawn, 2015 10
Vanda Pharmaceuticals Inc. - Phase II, 2015 11
Vanda Pharmaceuticals Inc. - Pipeline by Target, 2015 18
Vanda Pharmaceuticals Inc. - Pipeline by Route of Administration, 2015 19
Vanda Pharmaceuticals Inc. - Pipeline by Molecule Type, 2015 20
Vanda Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2015 21
Vanda Pharmaceuticals Inc. - Recent Pipeline Updates, 2015 22
Vanda Pharmaceuticals Inc. - Dormant Developmental Projects,2015 27
Vanda Pharmaceuticals Inc. - Discontinued Pipeline Products, 2015 28

List of Figures
Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Indication, 2015 6
Vanda Pharmaceuticals Inc. - Pipeline by Stage of Development, 2015 7
Vanda Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2015 8
Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Target, 2015 18
Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Route of Administration, 2015 19
Vanda Pharmaceuticals Inc. - Pipeline by Top 10 Molecule Type, 2015 20
Vanda Pharmaceuticals Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 21

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing